共 50 条
- [41] Missense mutations in SARS-CoV2 genomes from Indian patients GENOMICS, 2020, 112 (06) : 4622 - 4627
- [47] No arguments for extra risk from ibuprofen in SARS-COV2 infection THERAPIE, 2020, 75 (05): : 514 - 515
- [48] Updates From the NASPGHAN/SPLIT SARS-CoV2 International Registry JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (02): : E43 - E44
- [50] Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (09): : 481 - 483